XML 25 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Impairment
3 Months Ended
Mar. 31, 2023
Restructuring and Related Activities [Abstract]  
Impairment ImpairmentWe did not recognize any material impairment expense during the 2023 Quarter. During the 2022 Quarter, we reversed $63 million in impairment originally recognized in 2021 when our Stork and AMECO businesses were classified as held for sale due primarily to remeasurement under held and used impairment criteria, for which CTA balances are excluded from carrying value